EPISODE · Feb 14, 2026 · 4 MIN
Are weight-loss drugs the reason for Magnum ice cream sales slump?
from Down To Business
Magnum Ice Cream reported its first full-year results since its December demerger from Unilever, but posted a disappointing 3% drop in sales volumes in the fourth quarter but is it down to the widespread use of GLP-1 drugs? AJ Bell's Investment Director, Russ Mould joins Bobby to discuss.
Embed this episode
NOW PLAYING
Are weight-loss drugs the reason for Magnum ice cream sales slump?
0:00
4:11
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Down To Business?
This episode is 4 minutes long.
When was this Down To Business episode published?
This episode was published on February 14, 2026.
Can I download this Down To Business episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!